Photo: Alex Wong/Getty Images

President Trump came into office in 2017 with big ambitions on health care. But he’ll end this term with a lot less to show.

The big picture: If Trump ends up being a one-term president — and that’s not a prediction, just 1 of the 2 possibilities in 2020 — his health care legacy would be pretty modest.

Where it stands:

  • The administration scrapped its own plan to overhaul drug rebates. Its proposal to tie some drug prices to the prices European countries pay may not be finished by January 2021, leaving it in the hands of whoever wins in 2020.
  • A Democratic successor could stop approving Medicaid work requirements — one of Trump’s most impactful health policies — and perhaps even pressure states to ditch the requirements Trump approved. And that’s assuming the courts don’t put a definitive stop to work requirements first.

On the Affordable Care Act front, both Barack Obama and Trump changed the rules dictating how long consumers can keep short-term insurance plans; another Democrat could probably change them again. Actions like promoting ACA enrollment would be easy to resume.

Yes, but: Price transparency could become an exception — a real and lasting legacy, even from a one-term administration.

  • New rules require drugmakers to list their prices in their TV ads, and the administration has also proposed new price-disclosure rules for hospitals.
  • Those requirements would have to survive lawsuits from their respective industries, but they’re the kind of thing a Democratic administration might not want to reverse.
  • On the other end of the “Yes, but” spectrum is the lawsuit aiming to get the entire ACA struck down. As long as the odds may be, if the Trump administration gets its way, that would certainly count as a health care legacy.

What we’re watching: All of this also helps explain why the White House is so eager to strike a legislative deal on drug prices. Legislation is generally more durable than executive actions, and on health care, the administration needs something that can last.

Go deeper

Pence to continue traveling despite aides testing positive for COVID-19

Marc Short with Pence in March. Photo: Drew Angerer/Getty Images

Marc Short, Vice President Mike Pence’s chief of staff, tested positive for the coronavirus Saturday and is quarantining, according to a White House statement.

Why it matters: Short is Pence's closest aide, and was one of the most powerful forces on the White House coronavirus task force. Pence and second lady Karen Pence tested negative for the virus on Sunday morning, according to the vice president's office.

AOC: "Extremely important" that Biden offer Bernie Sanders a Cabinet position

Rep. Alexandria Ocasio-Cortez (D-N.Y.) said on CNN's "State of the Union" Sunday that she believes it's "extremely important" that Joe Biden offer Sen. Bernie Sanders and other progressive leaders Cabinet positions if he's elected president.

The big picture: Ocasio-Cortez was pressed repeatedly on policy differences between her and the more moderate Biden, including her opposition to fracking and support for Medicare for All. She responded that it would be a "privilege" and a "luxury" to be able to lobby a Biden administration on progressive issues, insisting that the focus right now should be on winning the White House.

1 hour ago - Health

Mark Meadows: "We are not going to control the pandemic"

White House Chief of Staff Mark Meadows defended Vice President Pence's decision to continue traveling and campaigning despite his exposure to aides who have tested positive for COVID-19, saying Sunday that Pence is exempt from CDC guidelines because he is "essential personnel."

Why it matters: CDC guidelines call for people who have been exposed to the virus to quarantine for 14 days. Meadows said on CNN's "State of the Union" that Pence will wear a mask when he travels and argued that "he's not just campaigning," pointing to the Israel-Sudan normalization agreement announced by the White House last week.